NICE’s final guidance recommending Bristol Myers Squibb’s first-in-class obstructive hypertrophic cardiomyopathy (oHCM) drug on the NHS, is now published.
Credit: HJBC / Shutterstock.comThe recommendation of...
Epyx's newly promoted head of account management for the UK and Europe, Jim Claridge, says he is "looking forward to the challenge".
Taking over management...
Recently, a former Goldman Sachs executive explained why he had “no issue” with XRP, the native digital asset of the open-source public XRP Ledger (XRPL), which was created...